Chemical Compound

orlistat

CAS Registry Number 96829-58-2

Back to search Request a Quote

Primary Record

orlistat

In stock: 6,819 g
Purity: 99.5 %
CAS: 96829-58-2

Compound Identifiers & Properties

CAS: 96829-58-2
PubChem CID: 3034010
SMILES: CCCCCCCCCCC[C@@H](C[C@H]1[C@@H](C(=O)O1)CCCCCC)OC(=O)[C@H](CC(C)C)NC=O
Canonical SMILES: CCCCCCCCCCC[C@@H](C[C@@H]1OC(=O)[C@H]1CCCCCC)OC(=O)[C@H](CC(C)C)NC=O

Names & Synonyms

orlistat
Tetrahydrolipstatin
Xenical
Orlipastat
Alli
96829-58-2
(-)-Tetrahydrolipstatin
Orlipastatum
orlistatum
tetrahydrolipastatin
THLP
Lipstatin
Beacita
Alii
Orlistat Powder
Orlipastatum [INN-Latin]
Orlistat API
Xenical (TN)
Orlistat (Standard)
Orlistat [USAN:INN]
zlchem 13
CIEC
Orlistat (Alli, Xenical)
Alli (TN)
AC1MHWQP
C29H53NO5
Lipase Inhibitor, THL
Roche brand of orlistat
ORLISTAT [HSDB]
ORLISTAT [USAN]
Orlistat (USAN/INN)
ORLISTAT [INN]
ORLISTAT [JAN]
Orlistat,Tetrahydolipstat
ORLISTAT [MI]
(-)-tetrahydrolipostatin
ORLISTAT [VANDF]
RefChem:389166
Orlistat [USAN:INN:BAN]
ORLISTAT [MART.]
DTXSID8023395
D0T9TJ
ORLISTAT [USP-RS]
ORLISTAT [WHO-DD]
MLS002207022
Ro 18-0647/002
CHEMBL175247
Orlistat (JAN/USP/INN)
ORLISTAT [EMA EPAR]
Orlistat, >=98%, solid
MFCD05662360
SCHEMBL16408
UNII-95M8R751W8
CHEBI:94686
HSDB 7556
MLS000759448
MLS001423955
Orlistat - Bio-X trade mark
BIDD:GT0853
DTXCID40820067
ORLISTAT [ORANGE BOOK]
GTPL5277
LEU002
orb1310386
Ro-18-0647
95M8R751W8
NSC-758881
ORLISTAT [USP MONOGRAPH]
BDBM24567
ERK5-3B20
HY-B0218R
Ro-18-0647/002
A08AB01
AOB6737
GlaxoSmithKline brand of orlistat
ZLA0015
AHLBNYSZXLDEJQ-FWEHEUNISA-N
Tetrahydrolipstatin;Ro-18-0647
GLXC-05010
HMS2051I08
HMS3413P06
HMS3677P06
HY-B0218
KS-1183
MSK10348
ZINC8214635
Hoffmann-La Roche brand of orlistat
Ro-180647002
Tox21_111437
BBF-03969
C29-H53-N-O5
EBC-11225
HB4009
Ro-180647-002
s1629
SMR000466339
AKOS015894875
Tox21_111437_1
ACN-038318
BCP9001031
CB11357
CCG-100851
CID3034010
CS-2165
CS-O-30994
DB01083
FO26582
NC00101
NSC 758881
RL06088
Ro18-0647
(2S)-1-[(2S,3S)-3-hexyl-4-oxooxetan-2-yl]tridecan-2-yl (2S)-2-formamido-4-methylpentanoate
NCGC00095128-01
NCGC00165856-01
NCGC00165856-02
NCGC00165856-03
NCGC00165856-14
NCGC00165856-15
R-212
Ro 18 0647
AN-15658
BC214880
BO164179
CPD000466339
R212
Ro 18-0647/008
SAM001246637
SC-16265
SY078600
BCP0726000044
Tetrahydrolipstatin|||Ro 18-0647/002
AB1009256
CAS-96829-58-2
J391.912I
LS-178328
N-Formyl-L-leucine (1S)-1-[[(2S,3S)-3-hexyl-4-oxo-2-oxetanyl]methyl]dodecyl ester
A8492
Alli, Xenical, Tetrahydrolipstatin, Orlistat
CS-0694775
L-Leucine, N-formyl-, (1S)-1-[[(2S,3S)-3-hexyl-4-oxo-2-oxetanyl]methyl]dodecyl ester
NS00004788
O0381
ST24048848
SW197481-2
Ro-18-0647-002
[(2S)-1-[(2S,3S)-3-hexyl-4-oxooxetan-2-yl]tridecan-2-yl] (2S)-2-formamido-4-methylpentanoate
A10676
D04028
EN300-268136
J90006
AB00639987-09
AB00639987_10
829O582
A845645
A983696
A983697
C055122
N-Formyl-L-leucine, ester with (3S,4S)-3-hexyl-4-((2S)-2-hydroxytridecyl)-2-oxetanone
Q424163
SR-01000759417
SR-01000759417-5
SR-01000759417-7
BRD-K63343048-001-12-2
BRD-K63343048-001-13-0
L-Leucine, N-formyl-, 1-((3-hexyl-4-oxo-2-oxetanyl)methyl)dodecyl ester, (2S-(2alpha(R*),3beta))-
Orlistat, 97%, General lipase inhibitor - 25MG 25mg
Z2379810072
L-Leucine, N-formyl-, (1S)-1-(((2S,3S)-3-hexyl-4-oxo-2-oxetanyl)methyl)dodecyl ester
(S)-1-((2S,3S)-3-hexyl-4-oxooxetan-2-yl)tridecan-2-yl formyl-L-leucinate
[(1S)-1-[[(2S,3S)-3-hexyl-4-oxo-oxetan-2-yl]methyl]dodecyl] (2S)-2-formamido-4-methyl-pentanoate
1-((3-hexyl-4-oxo-2-oxetanyl)methyl)dodecyl-2-formamido-4-methylvalerate
Orlistat, United States Pharmacopeia (USP) Reference Standard
(2S)-1-[(2S,3S)-3-hexyl-4-oxooxetan-2-yl]tridecan-2-yl N-formyl-L-leucinate
(S)-(S)-1-((2S,3S)-3-Hexyl-4-oxooxetan-2-yl)tridecan-2-yl 2-formamido-4-methylpentanoate
L-Leucine,N-formyl-, (1S)-1-(((2S,3S)-3-hexyl-4-oxo-2-oxetanyl)methyl)dodecyl ester
Orlistat, Pharmaceutical Secondary Standard; Certified Reference Material
2-formamido-3-[(3-hexyl-4-oxo-oxetan-2-yl)methyl]-2-isobutyl-tetradecanoate
N-Formyl-L-leucine (1S)-1-[[(2S)-3alpha-hexyl-4-oxooxetan-2beta-yl]methyl]dodecyl ester
N-formyl-L-leucine (1S)-1-{[(2S,3S)-3-hexyl-4-oxo-2-oxetanyl]methyl}dodecyl ester
N-Formyl-L-leucine (S)-1-[[(2S)-3alpha-hexyl-4-oxooxetane-2beta-yl]methyl]dodecyl ester
N-formyl-L-leucine (S)-1-[[(2S,3S)-3-hexyl-4-oxo-2-oxetanyl]methyl]dodecyl ester
N-formyl-L-leucine ester with (3S,4S)-3-hexyl-4-[(2S)-2-hydroxytridecyl]-2-oxetanone
N-formyl-L-leucine-(S)-1-[[(2S,3S)-3-hexyl-4-oxo-2-oxetanyl]methyl]-dodecyl ester
((2S)-1-((2S,3S)-3-hexyl-4-oxooxetan-2-yl)tridecan-2-yl) (2S)-2-formamido-4-methylpentanoate
(-)-Tetrahydrolipstatin; N-Formyl-L-leucine (1S)-1-[[(2S,3S)-3-hexyl-4-oxo-2-oxetanyl]methyl] dodecyl ester; Ro-18-0647
(-)-Tetrahydrolipstatin; Orlistat; Ro 18-0647/002; Tetrahydrolipstatin; Xenical; L-Leucine, N-formyl-, 1-[(3-hexyl-4-oxo-2-oxetanyl)methyl]dodecyl ester, [2S-[2alpha(R*),3beta]]-
(2S)-1-((2S,3S)-3-hexyl-4-oxooxetan-2-yl)tridecan-2-yl (2S)-2-formamido-4-methylpentanoate
(2S)-2-formamido-4-methylpentanoic acid [(2S)-1-[(2S,3S)-3-hexyl-4-oxo-2-oxetanyl]tridecan-2-yl] ester
(S)-((S)-1-((2S,3S)-3-hexyl-4-oxooxetan-2-yl)tridecan-2-yl) 2-formamido-4-methylpentanoate
(S)-2-FORMYLAMINO-4-METHYL-PENTANOICACID(S)-1-[[(2S,3S)-3-HEXYL-4-OXO-2-OXETANYL]METHYL]-DODECYLESTER
[(2S)-1-[(2R,3S)-3-hexyl-4-oxooxetan-2-yl]tridecan-2-yl] (2R)-2-formamido-4-methylpentanoate
104872-04-0
130193-40-7
130193-41-8
639-755-1
L-LEUCINE, N-FORMYL-, 1-((3-HEXYL-4-OXO-2-OXETANYL)METHYL)DODECYL ESTER, (2S-(2.ALPHA.(R*),3.BETA.))-
THL